You are here: Industry Insights > Market News > Pharma firm to pay $1.3B fine for vaccine scandal

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Aildenafil Citrate Tablets

Retatrutide 2381089-83-2

98% Bifida Ferment Lysate

rhSOD (cosmetic grade)

Recombinant humanized collagen

Recombinant Humanized Small-molecule Collagen

Pharma firm to pay $1.3B fine for vaccine scandal

biospectrumasiaOctober 19, 2018

Tag: Pharma , Vaccine , scandal

Favorites

Changchun Changsheng Life Sciences Ltd has been charged with a huge fine of $1.3 billion for falsifying production records in a scandal that prompted a nationwide crackdown on the vaccine industry.

Although no injuries were reported from use of Changsheng Life Science's rabies vaccines, authorities ordered a recall of its products from Chinese and foreign markets.

The pharma firm had used expired materials, mixed different batches of products and failed to test them properly. It was revealed that the company destroyed records to conceal its misconduct. 14 of its executives as well as its chairwoman were arrested while dozens were banned working in the drugs sector.

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.

Previous:PureTech affiliate Karuna advances schizophrenia candidate

Next:Robot addresses British MPs over future of AI

Xinhua Silk Road: Evaluation report highlights Seoul 120 hotline for its efficient operation

PRNewswireDecember 18, 2024

Seoul 120 hotline has contributed to efficient city operation, according to the Evaluation Report on Worldwide City Hotline Services and Governance Effectiveness (2024) released on Wednesday.

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 h

PRNewswireDecember 18, 2024

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Pr

PRNewswireDecember 18, 2024

Pharma firm to pay $1.3B fine for vaccine scandal | Pharmasources.com

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

PRNewswireDecember 19, 2024

Pharus Diagnostics LLC. (PharusDx), announced a significant step forward in the fight against pancreatic cancer. The company is announcing availability of its OncoSweep™ Pancreas Spotlight

You may like
More>>

Dibekacin sulfate JP15 Pharmaceutical Antibiotics made in china

Pharmaceutical PVC Blister Film for food and medicine packing

pidotimod-other active pharmaceutical ingredients

Closantel sodium CPV 98%min supplier Pharmaceutical API Antiparasitic Veterinary made in china

Zinc Stearate Chemical Pharmaceutical Plate Drying Machine

2-Hydroxypropyl-Beta-Cyclodextrin pharmaceutical intermediates

IPV(Inactivated Poliovirus Vaccine)

FEMA 2771 6%~95% Synephrine Citrus Aurantium Orangeblossomoil Plant extract Pharmaceutical API made

Marya GMP Standard Electronic Pharmaceutical Cleanroom Cargo Air Shower with High Efficiency System

Forsythin supplier API Plant extract Pharmaceutical made in china

Pharma firm to pay $1.3B fine for vaccine scandal

Related News

Xinhua Silk Road: Evaluation report highlights Seoul 120 hotline for its efficient operation

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 h

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Pr

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

You may likeMore>>

You may like
More>>